Table of Contents

Executive Summary

1 Industry Overview of Bio-pharma

• 1.1 Definition of Bio-pharma
• 1.2 Bio-pharma Segment by Type
  • 1.2.1 Global Bio-pharma Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Monoclonal Antibodies
  • 1.2.3 Recombinant Proteins
  • 1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF)
  • 1.2.5 Interferons
  • 1.2.6 Recombinant Human Insulin
  • 1.2.7 Erythropoietin
  • 1.2.8 Vaccines
  • 1.2.9 Growth Hormones
  • 1.2.10 Purified Proteins
  • 1.2.11 Others
• 1.3 Bio-pharma Segment by Applications
  • 1.3.1 Global Bio-pharma Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Metabolic Disorders
  • 1.3.3 Oncology
  • 1.3.4 Neurological Disorders
  • 1.3.5 Cardiovascular Diseases
  • 1.3.6 Inflammatory and Infectious Diseases
  • 1.3.7 Others
• 1.4 Global Bio-pharma Overall Market
  • 1.4.1 Global Bio-pharma Revenue (2014-2025)
  • 1.4.2 Global Bio-pharma Production (2014-2025)
  • 1.4.3 North America Bio-pharma Status and Prospect (2014-2025)
  • 1.4.4 Europe Bio-pharma Status and Prospect (2014-2025)
  • 1.4.5 China Bio-pharma Status and Prospect (2014-2025)
  • 1.4.6 Japan Bio-pharma Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Bio-pharma Status and Prospect (2014-2025)
  • 1.4.8 India Bio-pharma Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Bio-pharma
• 2.3 Manufacturing Process Analysis of Bio-pharma
• 2.4 Industry Chain Structure of Bio-pharma

3 Development and Manufacturing Plants Analysis of Bio-pharma

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Bio-pharma Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Bio-pharma
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Bio-pharma Production and Capacity Analysis
• 4.2 Bio-pharma Revenue Analysis
• 4.3 Bio-pharma Price Analysis
• 4.4 Market Concentration Degree

5 Bio-pharma Regional Market Analysis

• 5.1 Bio-pharma Production by Regions
  • 5.1.1 Global Bio-pharma Production by Regions
  • 5.1.2 Global Bio-pharma Revenue by Regions
• 5.2 Bio-pharma Consumption by Regions
• 5.3 North America Bio-pharma Market Analysis
  • 5.3.1 North America Bio-pharma Production
  • 5.3.2 North America Bio-pharma Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Bio-pharma Import and Export
• 5.4 Europe Bio-pharma Market Analysis
  • 5.4.1 Europe Bio-pharma Production
  • 5.4.2 Europe Bio-pharma Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Bio-pharma Import and Export
• 5.5 China Bio-pharma Market Analysis
  • 5.5.1 China Bio-pharma Production
  • 5.5.2 China Bio-pharma Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Bio-pharma Import and Export
• 5.6 Japan Bio-pharma Market Analysis
  • 5.6.1 Japan Bio-pharma Production
  • 5.6.2 Japan Bio-pharma Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Bio-pharma Import and Export
• 5.7 Southeast Asia Bio-pharma Market Analysis
  • 5.7.1 Southeast Asia Bio-pharma Production
  • 5.7.2 Southeast Asia Bio-pharma Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Bio-pharma Import and Export
• 5.8 India Bio-pharma Market Analysis
  • 5.8.1 India Bio-pharma Production
  • 5.8.2 India Bio-pharma Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Bio-pharma Import and Export

6 Bio-pharma Segment Market Analysis (by Type)

• 6.1 Global Bio-pharma Production by Type
• 6.2 Global Bio-pharma Revenue by Type
• 6.3 Bio-pharma Price by Type

7 Bio-pharma Segment Market Analysis (by Application)

• 7.1 Global Bio-pharma Consumption by Application
• 7.2 Global Bio-pharma Consumption Market Share by Application (2014-2019)

8 Bio-pharma Major Manufacturers Analysis

• 8.1 Pfizer
  • 8.1.1 Pfizer Bio-pharma Production Sites and Area Served
  • 8.1.2 Pfizer Product Introduction, Application and Specification
  • 8.1.3 Pfizer Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 F. Hoffmann-La Roche AG
  • 8.2.1 F. Hoffmann-La Roche AG Bio-pharma Production Sites and Area Served
  • 8.2.2 F. Hoffmann-La Roche AG Product Introduction, Application and Specification
  • 8.2.3 F. Hoffmann-La Roche AG Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Johnson & Johnson Services
  • 8.3.1 Johnson & Johnson Services Bio-pharma Production Sites and Area Served
  • 8.3.2 Johnson & Johnson Services Product Introduction, Application and Specification
  • 8.3.3 Johnson & Johnson Services Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Sanofi, Amgen
  • 8.4.1 Sanofi, Amgen Bio-pharma Production Sites and Area Served
  • 8.4.2 Sanofi, Amgen Product Introduction, Application and Specification
  • 8.4.3 Sanofi, Amgen Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 AbbVie
  • 8.5.1 AbbVie Bio-pharma Production Sites and Area Served
  • 8.5.2 AbbVie Product Introduction, Application and Specification
  • 8.5.3 AbbVie Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Merck & Co., Inc
  • 8.6.1 Merck & Co., Inc Bio-pharma Production Sites and Area Served
  • 8.6.2 Merck & Co., Inc Product Introduction, Application and Specification
  • 8.6.3 Merck & Co., Inc Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Biogen Idec
  • 8.7.1 Biogen Idec Bio-pharma Production Sites and Area Served
  • 8.7.2 Biogen Idec Product Introduction, Application and Specification
  • 8.7.3 Biogen Idec Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Bayer AG
  • 8.8.1 Bayer AG Bio-pharma Production Sites and Area Served
  • 8.8.2 Bayer AG Product Introduction, Application and Specification
  • 8.8.3 Bayer AG Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Eli Lilly and Company
  • 8.9.1 Eli Lilly and Company Bio-pharma Production Sites and Area Served
  • 8.9.2 Eli Lilly and Company Product Introduction, Application and Specification
  • 8.9.3 Eli Lilly and Company Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Novartis AG GlaxoSmithKline Plc
  • 8.10.1 Novartis AG GlaxoSmithKline Plc Bio-pharma Production Sites and Area Served
  • 8.10.2 Novartis AG GlaxoSmithKline Plc Product Introduction, Application and Specification
  • 8.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Bristol-Myers Squibb Company
• 8.12 AstraZeneca PLC
• 8.13 Abbott Laboratories

9 Development Trend of Analysis of Bio-pharma Market

• 9.1 Global Bio-pharma Market Trend Analysis
  • 9.1.1 Global Bio-pharma Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Bio-pharma Regional Market Trend
  • 9.2.1 North America Bio-pharma Forecast 2019-2025
  • 9.2.2 Europe Bio-pharma Forecast 2019-2025
  • 9.2.3 China Bio-pharma Forecast 2019-2025
  • 9.2.4 Japan Bio-pharma Forecast 2019-2025
  • 9.2.5 Southeast Asia Bio-pharma Forecast 2019-2025
  • 9.2.6 India Bio-pharma Forecast 2019-2025
• 9.3 Bio-pharma Market Trend (Product Type)
• 9.4 Bio-pharma Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Bio-pharma Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

The global Bio-pharma market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Bio-pharma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bio-pharma market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bio-pharma in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bio-pharma manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others

Segment by Application
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others